Combination therapy with intrapleural doxycycline and talc in reduced doses for pleurodesis Source: Annual Congress 2012 - Clinical issues in malignant pleural effusions Year: 2012
Variable adoption of intrapleural fibrinolytic therapy for pleural space infections Source: International Congress 2018 – Pleural interventions Year: 2018
Efficacy and safety of position selection combined with intra-pleural thrombin injection in the treatment of postoperative persistent air leakage Source: Virtual Congress 2021 – Novelties in interventional pulmonology Year: 2021
Ten years experience of use of intrapleural streptokinase (IPSK) for empyema Source: Eur Respir J 2001; 18: Suppl. 33, 319s Year: 2001
Use of intrapleural streptokinase and alteplase vs CTT alone in the resolution ofloculated pleural effusion among adult patients Source: International Congress 2019 – Clinical problems Year: 2019
Efficacy and safety of systemic and prolonged low-dose thrombolysis in thromboembolic disease Source: Eur Respir J 2002; 20: Suppl. 38, 478s Year: 2002
A clinical comparison of intrapleural heparin versus urokinase in the management of tuberculous pleurisy Source: Eur Respir J 2005; 26: Suppl. 49, 647s Year: 2005
Prognostic indexes for the efficacy of intrapleural instillation of bleomycin, alpha2-interferon and gamma-interferon in the control of malignant pleural effusions Source: Eur Respir J 2001; 18: Suppl. 33, 397s Year: 2001
An international survey on the use of intrapleural tissue plasminogen activator/DNase therapy for pleural infection Source: ERJ Open Res, 8 (1) 00590-2021; 10.1183/23120541.00590-2021 Year: 2022
A multicentre study evaluating bleeding risk with intrapleural enzyme therapy in pleural infection (RETROLYSIS) Source: Virtual Congress 2021 – Novelties in interventional pulmonology Year: 2021
Intrapleural fibrinolytic treatment with streptokinase for empyema during pregnancy: 2 cases Source: Annual Congress 2010 - Infections and pleural problems Year: 2010
Efficacy and safety of nebulized glycopyrrolate (EP-101) for administration using high efficiency nebulizer in patients with COPD Source: Annual Congress 2011 - Bronchodilators in asthma and COPD Year: 2011
Clinical efficacy of bolus versus continuous-infusion of piperacillin-tazobactam in VAP treatment Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections Year: 2011
Intrapleural fibrinolytic treatment of empyemas Source: Eur Respir J 2005; 26: Suppl. 49, 491s Year: 2005
Efficacy of intrapleural streptokinase use in complicated parapneumonic pleural effusions and empyema Source: Annual Congress 2008 - Pleural effusion Year: 2008
Comparison of two regimens of oral anticoagulation in pulmonary embolism Source: Eur Respir J 2006; 28: Suppl. 50, 632s Year: 2006
Safety and efficacy of intravenous (IV) Fosfomycin in adult cystic fibrosis patients Source: International Congress 2018 – Latest developments in cystic fibrosis Year: 2018
Long-term efficacy and safety of tobramycin 300mg/4mL nebuliser solution in patients with cystic fibrosis and chronic Pseudomonas aeruginosa infection Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new aspects of risk factors, treatments and diagnosis Year: 2012
Intrapleural heparin or heparin combined with human recombinant DNAase is not effective in the treatment of empyema in a rabbit model Source: Eur Respir J 2006; 28: Suppl. 50, 348s Year: 2006
Combination therapy in severe pulmonary hypertension with bosentan and treprostinil: successful switch from subcutaneous to intravenous application Source: Eur Respir J 2006; 28: Suppl. 50, 384s Year: 2006